Antongiulio Faggiano

Pubblicazioni

Titolo Pubblicato in Anno
Female sexual dysfunction in primary adrenal insufficiency JOURNAL OF CLINICAL MEDICINE 2021
Neuroendocrine Neoplasms with Peculiar Biology and Features. MEN1, MEN2A, MEN2B, MEN4, VHL, NF1 Neuroendocrine Neoplasia Management. New Approaches for Diagnosis and Treatment 2021
Are Markers of Systemic Inflammatory Response Useful in the Management of Patients With Neuroendocrine Neoplasms? FRONTIERS IN ENDOCRINOLOGY 2021
Commentary: case report: abdominal lymph node metastases of parathyroid carcinoma: diagnostic workup, molecular diagnosis, and clinical management FRONTIERS IN ENDOCRINOLOGY 2021
Multiparametric ultrasound evaluation of a case of bilateral carotid body tumor JOURNAL OF ULTRASOUND 2021
Somatostatin analogue therapy in men1-related pancreatic neuroendocrine tumors from evidence to clinical practice: a systematic review PHARMACEUTICALS 2021
A multicenter epidemiological study on second malignancy in non-syndromic pheochromocytoma/paraganglioma patients in Italy CANCERS 2021
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2021
Chronotype. what role in the context of gastroenteropancreatic neuroendocrine tumors? JOURNAL OF TRANSLATIONAL MEDICINE 2021
Foreword to the special issue on advances in neuroendocrine neoplasms REVIEWS IN ENDOCRINE & METABOLIC DISORDERS 2021
Neoadjuvant Therapy for Neuroendocrine Neoplasms. Recent Progresses and Future Approaches FRONTIERS IN ENDOCRINOLOGY 2021
Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper ESMO OPEN 2021
Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors FRONTIERS IN ENDOCRINOLOGY 2021
Pancreatic Neuroendocrine Tumors in Patients with Multiple Endocrine Neoplasia Type 1. Diagnostic Value of Different MRI Sequences NEUROENDOCRINOLOGY 2021
Editorial-Special Issue: Foreword to the Special Issue on NIKE: Neuroendocrine Tumors, Innovation in Knowledge and Education FRONTIERS IN ENDOCRINOLOGY 2021
Antineoplastic dosing in overweight and obese cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper ESMO OPEN 2021
Corrigendum to: "Quality of Life in Patients with Neuroendocrine Neoplasms: The Role of Severity, Clinical Heterogeneity, and Resilience" THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2021
Natural History and Management of Familial Paraganglioma Syndrome Type 1: Long-Term Data from a Large Family JOURNAL OF CLINICAL MEDICINE 2020
Thyroid profile during the alternative Sunitinib dosing 2/1 schedule in metastatic renal cell carcinoma ENDOCRINE 2020
Predictors of malignancy in high-risk indeterminate (TIR3B) cytopathology thyroid nodules JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2020

ERC

  • LS2_1
  • LS2_14
  • LS4_4
  • LS4_9
  • LS4_12
  • LS7_4
  • LS7_8
  • LS7_10
  • LS7_14

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

La principale area di ricerca sono è l'endocrinologia oncologica con numerose pubblicazioni e progetti clinici e traslazionali sulle neoplasie neuroendocrine, le neoplasie tiroidee, l'iperparatiroidismo, i tumori ipofisari, i feocromocitomi e paragangliomi, le sindromi neoplastiche genetiche multiendocrine. In tale ambito l'interesse di ricerca va dagli studi epidemiologici e di valutazione di fattori prognostici clinici e molecolari, studi sul ruolo della sindrome metabolica, della nutrizione e dei fatoori ambientali sulle neoplasie endocrine e neuroendocrine, studi genetici (ricerca nuove mutazioni, VUS, screening genetico, analisi NGS), studi diagnostici sulla diagnosi biochimica e ormonale e la diagnosi di imaging, studi terapeutici sull'efficacia e tossicità di farmaci biologici come analoghi della somatostatina, dopamino-agonisti, inibitori di mTOR, inibitori tirosino-chinasici. Più di recente interesse per l'andrologia, i tumori testicolari e le malattie genetiche della sfera andrologica

Keywords

neuroendocrine tumors (NETs)
Neuroendocrine neoplasms
multiple endocrine neoplasia type 1
Multiple Endocrine Neoplasia Type 2a/drug therapy
medullary thyroid cancer
Hyperparathyroidism
endocrine disrupting chemicals
Endocrine Gland Neoplasms
Endocrine function
andrological health
Pheochromocytoma

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma